Research Profile Overview
Turinabol Xeno Labs is a 4-chlorodehydromethyltestosterone oral anabolic steroid compound developed for comprehensive laboratory research applications. This synthetic androgenic steroid features a unique molecular structure derived from metandienone with chloro-substitution at the 4-position, creating distinct pharmacological properties for analytical investigation. Research institutions studying androgenic pathways and steroid biochemistry utilise this compound to examine anabolic-androgenic receptor interactions in controlled laboratory environments. The compound demonstrates reduced hepatotoxicity compared to methylated analogues in preclinical models, making it valuable for studying steroid metabolism and tissue-selective effects. Scientists at Stroid UK Shop investigate this compound’s unique binding affinity patterns and metabolic pathways.
Laboratory Research Applications
Research teams examine Turinabol’s tissue-selective androgenic activity in cellular assays and receptor binding studies. The compound’s moderate anabolic rating provides researchers with opportunities to study dose-response relationships in muscle tissue cultures and bone mineralisation models. Pharmaceutical research groups analyse its oral bioavailability characteristics and first-pass metabolism patterns to understand steroid pharmacokinetics. Comparative studies between Turinabol and other oral anabolic steroids help researchers understand structure-activity relationships. Scientists investigating hormone replacement protocols often compare its effects alongside selective androgen receptor modulators and peptide-based compounds to evaluate therapeutic potential and safety profiles in laboratory models.
Technical Specifications
| Active Compound | 4-Chlorodehydromethyltestosterone |
|---|---|
| CAS Number | 2446-23-3 |
| Molecular Formula | C₂₀H₂₇ClO₂ |
| Molecular Weight | 334.88 g/mol |
| Form | Oral tablets |
| Manufacturer | Xeno Labs |
| Storage | Room temperature, dry environment |
| Solubility | Ethanol, DMSO |
Research Use Compliance
Turinabol Xeno Labs is manufactured exclusively for in-vitro research and analytical laboratory applications. This compound is not intended for human consumption, clinical use, or any therapeutic applications. Research institutions must maintain appropriate laboratory protocols and comply with local regulations governing controlled substance research. Proper handling, storage, and disposal procedures must be followed according to institutional guidelines. All research activities should be conducted under appropriate supervision with adequate safety measures and documentation protocols.

